{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:34:56Z","timestamp":1786736096254,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Can Res Ther"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/jcrt.jcrt_564_18","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T09:26:33Z","timestamp":1565601993000},"page":"889","source":"Crossref","is-referenced-by-count":2,"title":["Anticancer effects of FL34 through the inhibition of GLI1 in glioblastoma"],"prefix":"10.4103","volume":"15","author":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueji","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiegang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0973-1482.264292-1","first-page":"941","volume-title":"The anti-cancer efficacies of diffractaic, lobaric, and usnic acid:In vitro inhibition of glioma","author":"Emsen","year":"2018","journal-title":"J Cancer Res Ther"},{"key":"key-10.4103\/0973-1482.264292-2","first-page":"1318","volume-title":"Gli1-induced deubiquitinase USP48 aids glioblastoma tumorigenesis by stabilizing gli1","author":"Zhou","year":"2017","journal-title":"EMBO Rep"},{"key":"key-10.4103\/0973-1482.264292-3","first-page":"2833","volume-title":"All-trans retinoic acid inhibits migration, invasion and proliferation, and promotes apoptosis in glioma cells in vitro","author":"Liang","year":"2015","journal-title":"Oncol Lett"},{"key":"key-10.4103\/0973-1482.264292-4","first-page":"146","volume-title":"Low incidence along with low mRNA levels of EGFR vIII in prostate and colorectal cancers compared to glioblastoma","author":"Peciak","year":"2017","journal-title":"J Cancer"},{"key":"key-10.4103\/0973-1482.264292-5","first-page":"181","volume-title":"Hedgehog beyond medulloblastoma and basal cell carcinoma","author":"Teglund","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"key-10.4103\/0973-1482.264292-6","first-page":"2454","volume-title":"Hedgehog: Functions and mechanisms","author":"Varjosalo","year":"2008","journal-title":"Genes Dev"},{"key":"key-10.4103\/0973-1482.264292-7","first-page":"1421","volume-title":"Inhibition of ciliogenesis promotes hedgehog signaling, tumorigenesis, and metastasis in breast cancer","author":"Hassounah","year":"2017","journal-title":"Mol Cancer Res"},{"key":"key-10.4103\/0973-1482.264292-8","first-page":"e88386","volume-title":"Down-regulation of Gli transcription factor leads to the inhibition of migration and invasion of ovarian cancer cells via integrin \u03b24-mediated FAK signaling","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"key-10.4103\/0973-1482.264292-9","first-page":"2033","volume-title":"Discovery of hedgehog antagonists for cancer therapy","author":"Khatra","year":"2017","journal-title":"Curr Med Chem"},{"key":"key-10.4103\/0973-1482.264292-10","first-page":"1168","volume-title":"Inhibition of hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells","author":"D'Amato","year":"2014","journal-title":"Br J Cancer"},{"key":"key-10.4103\/0973-1482.264292-11","first-page":"1256","volume-title":"A recurrent mosaic mutation in SMO, encoding the hedgehog signal transducer smoothened, is the major cause of Curry-Jones syndrome","author":"Twigg","year":"2016","journal-title":"Am J Hum Genet"},{"key":"key-10.4103\/0973-1482.264292-12","first-page":"S147","volume-title":"209P: SMO mutation is a strong negative prognostic factor in malignant pleural mesothelioma","author":"Signorelli","year":"2016","journal-title":"J Thorac Oncol"},{"key":"key-10.4103\/0973-1482.264292-13","first-page":"755","volume-title":"Mutation in exon 7 of PTCH deregulates SHH\/PTCH\/SMO signaling: Possible linkage to WNT","author":"Musani","year":"2006","journal-title":"Int J Mol Med"},{"key":"key-10.4103\/0973-1482.264292-14","first-page":"342","volume-title":"Smoothened variants explain the majority of drug resistance in basal cell carcinoma","author":"Atwood","year":"2015","journal-title":"Cancer Cell"},{"key":"key-10.4103\/0973-1482.264292-15","first-page":"327","volume-title":"Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma","author":"Sharpe","year":"2015","journal-title":"Cancer Cell"},{"key":"key-10.4103\/0973-1482.264292-16","first-page":"133","volume-title":"Essential role of Gli proteins in glioblastoma multiforme","author":"Santoni","year":"2013","journal-title":"Curr Protein Pept Sci"},{"key":"key-10.4103\/0973-1482.264292-17","first-page":"371","volume-title":"Sonic hedgehog (SHH) and glioblastoma-2 (Gli-2) expressions are associated with poor jaundice-free survival in biliary atresia","author":"Jung","year":"2015","journal-title":"J Pediatr Surg"},{"key":"key-10.4103\/0973-1482.264292-18","first-page":"392","volume-title":"The molecular mechanisms of a novel multi-kinase inhibitor ZLJ33 in suppressing pancreatic cancer growth","author":"Li","year":"2015","journal-title":"Cancer Lett"},{"key":"key-10.4103\/0973-1482.264292-19","first-page":"114","volume-title":"Brain tumors","author":"DeAngelis","year":"2001","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0973-1482.264292-20","first-page":"154","volume-title":"Mitogen-activated protein kinases and hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities?","author":"Rovida","year":"2015","journal-title":"Semin Cancer Biol"},{"key":"key-10.4103\/0973-1482.264292-21","first-page":"7724","volume-title":"Activation of the BCL2 promoter in response to hedgehog\/GLI signal transduction is predominantly mediated by GLI2","author":"Regl","year":"2004","journal-title":"Cancer Res"},{"key":"key-10.4103\/0973-1482.264292-22","first-page":"10","volume-title":"Sonic hedgehog signaling pathway induces cell migration and invasion through focal adhesion kinase\/AKT signaling-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9 in liver cancer","author":"Chen","year":"2013","journal-title":"Carcinogenesis"},{"key":"key-10.4103\/0973-1482.264292-23","first-page":"200","volume-title":"Gli1\/DNA interaction is a druggable target for hedgehog-dependent tumors","author":"Infante","year":"2015","journal-title":"EMBO J"},{"key":"key-10.4103\/0973-1482.264292-24","first-page":"119","volume-title":"Genetic variations and alternative splicing: The glioma associated oncogene 1, GLI1","author":"Zaphiropoulos","year":"2012","journal-title":"Front Genet"},{"key":"key-10.4103\/0973-1482.264292-25","first-page":"633","volume-title":"The GANT61, a GLI inhibitor, induces caspase-independent apoptosis of SK-N-LO cells","author":"Matsumoto","year":"2014","journal-title":"Biol Pharm Bull"},{"key":"key-10.4103\/0973-1482.264292-26","first-page":"14048","volume-title":"Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells","author":"Ji","year":"2007","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0973-1482.264292-27","first-page":"4505","volume-title":"Phosphoinositide 3-kinase and akt are essential for sonic hedgehog signaling","author":"Riob\u00f3","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/0973-1482.264292-28","first-page":"5895","volume-title":"Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK\/AKT pathways","author":"Stecca","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/0973-1482.264292-29","first-page":"51ra70","volume-title":"Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma","author":"Buonamici","year":"2010","journal-title":"Sci Transl Med"},{"key":"key-10.4103\/0973-1482.264292-30","first-page":"437","volume-title":"GLI transcription factors: Mediators of oncogenic hedgehog signalling","author":"Kasper","year":"2006","journal-title":"Eur J Cancer"},{"key":"key-10.4103\/0973-1482.264292-31","first-page":"33","volume-title":"The 150 most important questions in cancer research and clinical oncology series: Questions 6-14: Edited by Chinese Journal of Cancer","author":"Chinese","year":"2017","journal-title":"Chin J Cancer"},{"key":"key-10.4103\/0973-1482.264292-32","first-page":"203","volume-title":"Matrix metalloproteinases as therapeutic targets in cancer","author":"Vihinen","year":"2005","journal-title":"Curr Cancer Drug Targets"},{"key":"key-10.4103\/0973-1482.264292-33","first-page":"71","volume-title":"FAK is involved in invasion and metastasis of hepatocellular carcinoma","author":"Chen","year":"2010","journal-title":"Clin Exp Metastasis"},{"key":"key-10.4103\/0973-1482.264292-34","first-page":"2646","volume-title":"Hedgehog controls neural stem cells through p53-independent regulation of Nanog","author":"Po","year":"2010","journal-title":"EMBO J"},{"key":"key-10.4103\/0973-1482.264292-35","first-page":"84","volume-title":"Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals","author":"Stecca","year":"2010","journal-title":"J Mol Cell Biol"},{"key":"key-10.4103\/0973-1482.264292-36","first-page":"184","volume-title":"GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment","author":"Li","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"key":"key-10.4103\/0973-1482.264292-37","first-page":"27000","volume-title":"Investigating the role of hedgehog\/GLI1 signaling in glioblastoma cell response to temozolomide","author":"Melamed","year":"2018","journal-title":"Oncotarget"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:37:16Z","timestamp":1786732636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_564_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"alternative-id":["264292"],"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_564_18","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}